Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bessette

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Plos One|July 6, 2023
The impact of electronic health record discontinuity on prediction modelingShreyas Kar, Lily G Bessette, Richard Wyss, et al.
Clinical Epidemiology|April 22, 2024
Development and Validation of an Intracranial Hemorrhage Risk Score in Older Adults with Atrial Fibrillation Treated with Oral AnticoagulantLily G Bessette, Daniel E Singer, Ajinkya Pawar, et al.
American Journal of Epidemiology|August 31, 2023
Development and Validation of a Claims-Based Model to Predict Categories of ObesityKarine Suissa, Richard Wyss, Zhigang Lu, et al.
Clinical Epidemiology|March 21, 2023
Development and Validation of a Novel Tool to Predict Model for End-Stage Liver Disease (MELD) Scores in Cirrhosis, Using Administrative DatasetsTracey G Simon, Sebastian Schneeweiss, Richard Wyss, et al.
Annals of Internal Medicine|July 19, 2021
Frailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation : A Cohort StudyDae Hyun Kim, Ajinkya Pawar, Joshua J Gagne, et al.
JAMA Network Open|March 28, 2023
Comparative Effectiveness and Safety of Oral Anticoagulants by Dementia Status in Older Patients With Atrial FibrillationKueiyu Joshua Lin, Daniel E Singer, Katsiaryna Bykov, et al.
Clinical Pharmacology and Therapeutics|June 27, 2023
Predicting Treatment Effects of a New-to-Market Drug in Clinical Practice Based on Phase III Randomized Trial ResultsHoJin Shin, Shirley V Wang, Dae Hyun Kim, et al.
Clinical Pharmacology and Therapeutics|December 18, 2022
Scalable Feature Engineering from Electronic Free Text Notes to Supplement Confounding Adjustment of Claims-Based Pharmacoepidemiologic StudiesRichard Wyss, Joseph M Plasek, Li Zhou, et al.
Pharmacoepidemiology and Drug Safety|December 15, 2021
Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims dataJulie M Paik, Elisabetta Patorno, Min Zhuo, et al.
Journal of the American Geriatrics Society|June 24, 2023
Common non-cardiovascular multimorbidity groupings and clinical outcomes in older adults with major cardiovascular diseaseStephanie Denise M Sison, Kueiyu Joshua Lin, Mehdi Najafzadeh, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Plos One|July 6, 2023
The impact of electronic health record discontinuity on prediction modelingShreyas Kar, Lily G Bessette, Richard Wyss, et al.
Clinical Epidemiology|April 22, 2024
Development and Validation of an Intracranial Hemorrhage Risk Score in Older Adults with Atrial Fibrillation Treated with Oral AnticoagulantLily G Bessette, Daniel E Singer, Ajinkya Pawar, et al.
American Journal of Epidemiology|August 31, 2023
Development and Validation of a Claims-Based Model to Predict Categories of ObesityKarine Suissa, Richard Wyss, Zhigang Lu, et al.
Clinical Epidemiology|March 21, 2023
Development and Validation of a Novel Tool to Predict Model for End-Stage Liver Disease (MELD) Scores in Cirrhosis, Using Administrative DatasetsTracey G Simon, Sebastian Schneeweiss, Richard Wyss, et al.
Annals of Internal Medicine|July 19, 2021
Frailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation : A Cohort StudyDae Hyun Kim, Ajinkya Pawar, Joshua J Gagne, et al.
JAMA Network Open|March 28, 2023
Comparative Effectiveness and Safety of Oral Anticoagulants by Dementia Status in Older Patients With Atrial FibrillationKueiyu Joshua Lin, Daniel E Singer, Katsiaryna Bykov, et al.
Clinical Pharmacology and Therapeutics|June 27, 2023
Predicting Treatment Effects of a New-to-Market Drug in Clinical Practice Based on Phase III Randomized Trial ResultsHoJin Shin, Shirley V Wang, Dae Hyun Kim, et al.
Clinical Pharmacology and Therapeutics|December 18, 2022
Scalable Feature Engineering from Electronic Free Text Notes to Supplement Confounding Adjustment of Claims-Based Pharmacoepidemiologic StudiesRichard Wyss, Joseph M Plasek, Li Zhou, et al.
Pharmacoepidemiology and Drug Safety|December 15, 2021
Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims dataJulie M Paik, Elisabetta Patorno, Min Zhuo, et al.
Journal of the American Geriatrics Society|June 24, 2023
Common non-cardiovascular multimorbidity groupings and clinical outcomes in older adults with major cardiovascular diseaseStephanie Denise M Sison, Kueiyu Joshua Lin, Mehdi Najafzadeh, et al.
Pageof 5